Business Context and Reporting Period
Company: Omeros Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 1, 2019
Reporting Period: The filing announces financial results for the three months and the full year ended December 31, 2018. The specific financial data is contained in a press release furnished as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for the actual financial data. Consequently, the filing text itself does not provide clear values for the following metrics:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus the prior comparable period. Investors must refer to the referenced press release (Exhibit 99.1) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release by the company but does not include the text of management commentary, forward-looking guidance, or specific risk factors within this document.
Legal Disclaimer: The filing explicitly states that the information contained herein and in the accompanying exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 1, 2019) for actual revenue, net loss, and cash position figures.
- Verify the specific clinical trial updates or product development milestones mentioned in the referenced press release.
- Confirm the company's cash runway and burn rate as detailed in the full financial results.
- Check for any updated guidance on future product launches or regulatory approvals.